Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

VEEV vs IQV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEV Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–4 Matrix Metrics)

VEEV Overall Winner 6-Pillar Tally: VEEV 5 – 1 IQV Matrix Metrics: VEEV 5 – 4 IQV

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over IQVIA Holdings Inc. (IQV) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEV carries a Unified Composite Score of 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin), whereas IQV carries 60.2/100 (BUY) at $258.94 (18.6x Forward P/E, 13.9% operating margin).

  • Composite vs. Pillar Nuance: While IQV currently prints a higher short-term Unified Composite Score (60.2/100 BUY vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 13.9% operating margin) and revenue trajectory (+17.6% vs. +8.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VEEV vs IQV
VEEV NYSE Head-to-Head Winner
Veeva Systems Inc.
Services-Prepackaged Software
$290.25
-3.02% 1D
Market Cap $48.8B
TTM Revenue $3.46B
Forward P/E 34.8x
Beta / 30D Vol 0.39β · 20% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 68.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.9 · SMA20: $309.35 · SMA50: $292.48
IQV NYSE
IQVIA Holdings Inc.
Services-Commercial Physical & Biological Research
$258.94
-2.19% 1D
Market Cap $43.7B
TTM Revenue $17.3B
Forward P/E 18.6x
Beta / 30D Vol 0.39β · 30% Vol
Unified Composite Score
60.2 / 100 BUY
Tech 50.0 Fund 52.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.3 · SMA20: $270.54 · SMA50: $267.35

6-Pillar Scorecard Institutional Category Breakdown (VEEV 5 – 1 IQV)

Columns: Metric · VEEV · IQV
1. Valuation Multiples IQV
Forward P/E 34.8x 18.6x
Trailing P/E 49.4x 32.2x
PEG Ratio 1.16x 0.98x
EV / Revenue 13.6x 3.3x
2. Growth & Scale VEEV
Revenue Growth (YoY) +17.6% +8.0%
Earnings Growth (YoY) +39.5% +8.8%
TTM Revenue (USD) $3.46B $17.3B
Market Cap $48.8B $43.7B
3. Profitability & Quality VEEV
Gross Margin 75.0% 33.1%
Operating Margin 29.9% 13.9%
Net Profit Margin 29.3% 8.1%
Return on Equity (ROE) 14.4% 21.4%
4. Balance Sheet & Cash Flow VEEV
Cash Generation (TTM) $1.67B $2.08B
Cash Flow Margin 48.2% 12.0%
Net Cash / Leverage $1.66B Net Cash $14.1B Net Debt (2.45x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VEEV
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 45.0% (55th %ile) 36.5% (3rd %ile)
Put/Call OI Skew 0.71x (Call-Skewed) 0.60x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat VEEV
OpEx & R&D Intensity 45.1% of Rev ($1.56B) 19.2% of Rev ($3.32B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Health Information Services Operator Diagnostics & Research Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VEEV (5) vs IQV (4)
Institutional Metric VEEV IQV Criterion Row Edge
Market Capitalization
Scale
$48.8B $43.7B Larger Scale VEEV
Trailing P/E Ratio
Valuation
49.4x 32.2x Lower Multiple IQV
Forward P/E Ratio
Valuation
34.8x 18.6x Lower Multiple IQV
Revenue Growth (YoY)
Growth
+17.6% +8.0% Higher Growth VEEV
Operating Margin (TTM)
Profitability
29.9% 13.9% Higher Margin VEEV
Net Profit Margin
Profitability
29.3% 8.1% Higher Margin VEEV
Return on Equity (ROE)
Capital Efficiency
14.4% 21.4% Higher ROE IQV
52-Week Range Position
Momentum
80% ($148–$326) 80% ($154–$284) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
0.39β · 20% Vol 0.39β · 30% Vol Lower Realized Risk VEEV
Unified Institutional Score
Composite Signal
48.5 / 100 (HOLD) 60.2 / 100 (BUY) Higher Composite IQV
Trailing 12M Revenue (USD)
Operating Scale
$3.46B $17.3B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
75.0% 33.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.16x PEG · 13.6x EV/Rev 0.98x PEG · 3.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.67B ($1.66B Net Cash) $2.08B ($14.1B Net Debt (2.45x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IQV +5.77 pp
VEEV: -8.38% · IQV: -2.61%
3M Horizon VEEV +11.76 pp
VEEV: +15.64% · IQV: +3.88%
6M Horizon VEEV +28.21 pp
VEEV: +77.73% · IQV: +49.52%
1Y Horizon IQV +18.44 pp
VEEV: -1.06% · IQV: +17.38%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VEEV Revenue IQV Revenue VEEV Op. Margin IQV Op. Margin Margin Leader
FY2019 $860M $11.1B 25.8% 7.0% VEEV
FY2020 $1.10B $11.4B 25.9% 6.4% VEEV
FY2021 $1.47B $13.9B 25.8% 10.0% VEEV
FY2022 $1.85B $14.4B 27.3% 12.5% VEEV
FY2023 $2.16B $15.0B 21.3% 13.2% VEEV
FY2024 $2.36B $15.4B 18.2% 14.3% VEEV
FY2025 $2.75B $16.3B 25.2% 13.4% VEEV
FY2026 $3.20B N/A 28.7% N/A VEEV

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VEEV CONSOLIDATION
55d in phase · OBV DISTRIBUTION
Current IV 45.0%
IV Percentile 55th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact VEEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IQV CONSOLIDATION
52d in phase · OBV DISTRIBUTION
Current IV 36.5%
IV Percentile 3rd %ile
Put/Call OI Skew 0.60x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact IQV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $299.28 · IV 50.8%

VEEV vs. IQV: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of VEEV ($29,928) vs. IQV ($26,206) against risk-defined 5-day vertical and put-wall option structures.

VEEV Spot $299.28 · IV 50.8%
VEEV Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $300 / $330 Bull Call Spread

Buy 1x $300C · Sell 1x $330C · 32d

Net Entry $1,140 Debit
T+5d @ +5% Move +$352 (+31%)
Max Risk / Buffer $1,140 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $280 / $260 Bull Put Spread

Sell 1x $280P · Buy 1x $260P · 32d

Net Entry $478 Credit
Max Credit / Yield +$478 (+31.4% RoM)
Max Risk / Buffer -8.0% Cushion ($1,522 Mgn)
5d Edge & Liquidity 71% PoP · Liq B
Simulate 5-Day Payoff →
IQV Spot $262.06 · IV 39.1%
IQV Options Simulator →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $250 / $240 Bull Put Spread

Sell 1x $250P · Buy 1x $240P · 31d

Net Entry $300 Credit
Max Credit / Yield +$300 (+42.9% RoM)
Max Risk / Buffer -5.7% Cushion ($700 Mgn)
5d Edge & Liquidity 70% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $260 / $250 Bear Put Spread

Buy 1x $260P · Sell 1x $250P · 31d

Net Entry $430 Debit
T+5d @ -5% Drop +$188 (+44%)
Max Risk / Buffer $430 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VEEV Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $48.8B market capitalization and 29.9% operating margin.
OpEx & R&D Reinvestment 45.1% of Rev ($1.56B)
90D Engineering Disclosures 0 Published
IQV Moat Profile Scale & Operating Efficiency Moat
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $43.7B market capitalization and 13.9% operating margin.
OpEx & R&D Reinvestment 19.2% of Rev ($3.32B)
90D Engineering Disclosures 0 Published

Investor FAQ VEEV vs IQV Key Questions & Quantitative Answers

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over IQVIA Holdings Inc. (IQV) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEV carries a Unified Composite Score of 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin), whereas IQV carries 60.2/100 (BUY) at $258.94 (18.6x Forward P/E, 13.9% operating margin). Composite vs. Pillar Nuance: While IQV currently prints a higher short-term Unified Composite Score (60.2/100 BUY vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 13.9% operating margin) and revenue trajectory (+17.6% vs. +8.0% YoY).

VEEV leads the Growth & Scale pillar: VEEV posts +17.6% YoY revenue growth and +39.5% YoY earnings growth on $3.46B TTM revenue (75.0% gross margin, 29.9% operating margin), compared with IQV at +8.0% YoY revenue growth and +8.8% YoY earnings growth on $17.3B TTM revenue (33.1% gross margin, 13.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VEEV cumulative revenue shifted +272.1% while IQV shifted +47.1%. In operating R&D and SG&A reinvestment, VEEV deploys 45.1% of Rev ($1.56B) (0 90-day corporate R&D disclosures) versus 19.2% of Rev ($3.32B) (0 disclosures) for IQV.

IQV screens cheaper on headline valuation multiples. VEEV trades at 34.8x Forward P/E, 49.4x Trailing P/E, 1.16x PEG, and 13.6x EV/Revenue (48.2% FCF margin), whereas IQV trades at 18.6x Forward P/E, 32.2x Trailing P/E, 0.98x PEG, and 3.3x EV/Revenue (12.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VEEV (14.4% ROE) versus IQV (21.4% ROE) capital efficiency.

In options market volatility and institutional positioning, VEEV carries 45.0% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 20% Vol realized risk). By comparison, IQV carries 36.5% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.60x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 30% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.